Welcome to LookChem.com Sign In|Join Free
  • or
Pentanoic acid, 4-[(5-nitro-2-pyridinyl)dithio]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

663598-55-8

Post Buying Request

663598-55-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

663598-55-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 663598-55-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,3,5,9 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 663598-55:
(8*6)+(7*6)+(6*3)+(5*5)+(4*9)+(3*8)+(2*5)+(1*5)=208
208 % 10 = 8
So 663598-55-8 is a valid CAS Registry Number.

663598-55-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(5-nitropyridin-2-yl)disulfanyl]pentanoic acid

1.2 Other means of identification

Product number -
Other names Pentanoic acid,4-[(5-nitro-2-pyridinyl)dithio]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:663598-55-8 SDS

663598-55-8Downstream Products

663598-55-8Relevant academic research and scientific papers

NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF

-

Page/Page column 71, (2018/04/13)

Provided herein are novel maytansinoid compounds of general formula I. Also provided herein are conjugates comprising the compounds linked to a binding protein via a linker, and conjugating reagents comprising the compounds attached via a linker to at least one functional group capable of reacting with a binding protein. Also provided herein are pharmaceutical compositions comprising the compounds and conjugates, therapeutic methods and uses involving the compounds and conjugates, for example in cancer therapy, and novel synthetic processes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 663598-55-8